Identification of New Biomarker for Alzheimer’s Could Set Stage for Clinical Laboratory Test to Identify and Diagnosis the Disease in Its Early Stages

Initial skin test research shows promise but larger clinical studies needed before diagnostic tool could be ready for use by medical laboratories and pathologists Researchers in Mexico developed a skin test that could lead to the early diagnosis of Alzheimer’s disease and pave the way for new therapies to treat a disease ranked as the sixth leading cause of death in the United States. For clinical pathologists and medical laboratories, a testing breakthrough would be significant since the...
;